Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Tafamidis meglumine
Tafamidis meglumine
951395-08-7
|
502.091
|
4.998
Tafamidis stabilizes transthyretin tetramers, reducing the amount of monomers available for amyloidogenesis. Tafamidis is indicated to treat cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis in adults.
6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole meglumine | tafamidis meglumine
Tafamidis stabilizes transthyretin tetramers, reducing the amount of monomers available for amyloidogenesis. Tafamidis is indicated to treat cardiomyopathy of wild type or hereditary transthyretin-mediated amyloidosis in adults.
6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole meglumine | tafamidis meglumine
$41/5 mg
(EBC)
1
CAS:594839-88-0
0
We provide 0 compound for Tafamidis meglumine